|
LEXX Lexaria Bioscience Corp 1348362 |
| Balance Sheet |
|
Current Assets
|
$4,064,869.00 |
|
Assets
|
$4,781,331.00 |
|
Current Liabilities
|
$383,412.00 |
|
Liabilities
|
$437,091.00 |
|
Equity
|
$4,738,210.00 |
|
Shares Out
|
24787446.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,782,990.00 |
|
Investing Cash Flow
|
$-86,097.00 |
| Market Analysis |
Market Cap
|
$279,354,516.42 |
|
Price
|
$3.24 |
|
BVPS
|
0.19 |
|
PB
|
59.32 |
|
EPS
|
-0.08 |
|
PS
|
379.72 |
|
FCF
|
$-4,823,806.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:59 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:49 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LEXX documents filed with the SEC.
LEXX Filings
Clear
